Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 1,362 trials
Active filters
Clinical trials found
Published and searchable clinical trials
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
NCT07634471
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- SCRI Oncology Partners ( Site 7000) Nashville, Tennessee, United States
- Hadassah Medical Center ( Site 0701) Jerusalem, Israel
- Sheba Medical Center ( Site 0702) Ramat Gan, Israel
- Sourasky Medical Center ( Site 0704) Tel Aviv, Israel
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
NCT07424833
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Henan Cancer Hospital Zhengzhou, Henan, China
- START Los Angele Los Angeles, California, United States
- START Midwest Grand Rapids, Michigan, United States
NCT07197307
- Conditions
- Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany
- Universitaetsklinikum Aachen Aachen, Germany
- Universitaetsklinikum Augsburg Augsburg, Germany
- Vivantes Netzwerk fuer Gesundheit Berlin, Germany
NCT06785818
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
- Locations
-
- Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
- Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
- Novartis Investigative Site Gyeonggi-do, Korea, South Korea
- Novartis Investigative Site Incheon, Korea, South Korea
A Study of ARC-02 in B-cell NHL
NCT07691606
- Conditions
- B-cell Non Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Start Cala Los Angeles, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- NYU Langone New York, United States
- Levine Cancer Institute Charlotte, North Carolina, United States
NCT07519772
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Colorado Blood Cancer Institute ( Site 7000) Denver, Colorado, United States
- SCRI Oncology Partners ( Site 0100) Nashville, Tennessee, United States
- Instituto Alexander Fleming ( Site 1404) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Sanatorio Nuestra Senora del Rosario ( Site 1403) Rosario, Santa Fe Province, Argentina
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
- Locations
-
- City of Hope Duarte, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center - Bergen New York, United States
NCT06860594
- Conditions
- Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Glioblastoma, +22 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Conditions
- Astrocytoma, Astrocytoma, Grade III, Glioblastoma, +17 more
- Locations
-
- Northwestern Memorial Hospital Chicago, Illinois, United States
- New York University Langone Medical Center New York, United States
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
- Baylor Scott & White Research Institute Dallas, Texas, United States
NCT07630545
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more
- Locations
-
- The Royal Adelaide Hospital Adelaide, Australia
- Doherty Clinical Trials Melbourne, Australia
- Monash Health, Kingston Centre Melbourne, Australia
- Centre Hospitalier Universitaire de Lille, Institut Cœur Poumon Lille, France
Clonal Evolution in Follicular Lymphoma
NCT03190928
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
NCT05006716
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
NCT06542250
- Conditions
- B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site Rochester, Minnesota, United States
- Research Site Hackensack, New Jersey, United States
NCT07154823
- Conditions
- Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL), Hematologic Diseases, +15 more
- Locations
-
- University of Iowa Hospital and Clinics Iowa City, Iowa, United States
- The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
- Washington University in St. Louis St Louis, Missouri, United States
- Cancer Care Specialists of Reno Reno, Nevada, United States
NCT06471738
- Conditions
- Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma, +13 more
- Locations
-
- Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital Beijing, China
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
NCT06549595
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Research Site Huntsville, Alabama, United States
- Research Site Anchorage, Alaska, United States
- Research Site Phoenix, Arizona, United States
- Research Site Clovis, California, United States
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
NCT06651177
- Conditions
- Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Gateway Community Services Jacksonville, Florida, United States
- IBIS Behavioral Health Tampa, Florida, United States
- Ruth M. Rothstein CORE Center Chicago, Illinois, United States
- The Gibson Center for Behavioral Change Cape Girardeau, Missouri, United States
NCT05064319
- Conditions
- Bipolar Disorder, Bipolar I Disorder, Bipolar II Disorder, +20 more
- Locations
-
- Medical University Of South Carolina Charleston, South Carolina, United States
NCT07226843
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
- City of Hope Duarte, California, United States
- University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States
- University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States